A unique range of over 3000 novel substituted fluoro aromatic compounds functionalised with a variety of synthetically useful reactive groups.
US regulators have further expanded the scope of Bristol Myers Squibb’s Opdivo, approving its use for a previously treated small...
Read More >
Recent launch of several new categories of compound which include the spirocyclic β-Lactams designed...
Read More >